Omaxe Cost Of Revenue from 2010 to 2025

OMAXE Stock   79.94  1.57  1.93%   
Omaxe Cost Of Revenue yearly trend continues to be very stable with very little volatility. Cost Of Revenue is likely to drop to about 8.9 B. During the period from 2010 to 2025, Omaxe Cost Of Revenue quarterly data regression pattern had sample variance of 15625821.1 T and median of  11,851,830,000. View All Fundamentals
 
Cost Of Revenue  
First Reported
2011-09-30
Previous Quarter
5.7 B
Current Value
3.7 B
Quarterly Volatility
1.3 B
 
Yuan Drop
 
Covid
Check Omaxe financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omaxe's main balance sheet or income statement drivers, such as Depreciation And Amortization of 592.8 M, Interest Expense of 1 B or Selling General Administrative of 257.5 M, as well as many indicators such as . Omaxe financial statements analysis is a perfect complement when working with Omaxe Valuation or Volatility modules.
  
This module can also supplement various Omaxe Technical models . Check out the analysis of Omaxe Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Omaxe Stock

Omaxe financial ratios help investors to determine whether Omaxe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Omaxe with respect to the benefits of owning Omaxe security.